COMPANY
Clinical Phase 2
Keywords: exocrine pancreatic insufficiency cystic fibrosis gastroenterology ANG003
Profile checked Oct 10, 2026
Timeline
- Trial start 2: Phase 2 Study to Assess the Safety and Efficacy of ANG003 source ↗
- Trial start 1: Phase 1 Study to Assess Safety and Efficacy of ANG003 source ↗
Upcoming milestones
- 2027-07 (ESTIMATED) · 2 · Phase 2 Study to Assess the Safety and Efficacy of ANG003 · NCT07450547
Estimated primary completion per ClinicalTrials.gov. Dates move.
Clinical trials (lead sponsor) 2
| Record | Title | Phase | Status | Start | Primary completion |
|---|
| NCT07450547 | Phase 2 Study to Assess the Safety and Efficacy of ANG003 | 2 | Recruiting | Apr 24, 2026 | 2027-07 (estimated) |
| NCT06052293 | Phase 1 Study to Assess Safety and Efficacy of ANG003 | 1 | Completed | Aug 25, 2023 | Jul 8, 2024 (actual) |
